Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
112.3 USD | +3.87% |
|
+7.62% | +2.41% |
08/07 | Leerink Initiates Revvity at Outperform With $125 Price Target | MT |
27/06 | Barclays Trims Price Target on Revvity to $115 From $116 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.41% | 13.34B | |
+4.11% | 208B | |
+8.31% | 182B | |
+29.04% | 155B | |
+34.37% | 115B | |
+2.55% | 66.52B | |
+14.82% | 53.93B | |
-6.47% | 46.26B | |
-3.01% | 38.22B | |
+6.05% | 36.6B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : PerkinElmer, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 08